Clinical and genetic spectrum of SCN2A gene associated epilepsy and episodic ataxia.
10.3760/cma.j.cn112140-20210610-00491
- Author:
Jing GUAN
1
;
Kai Xian DU
1
;
Yan DONG
1
;
Lin LI
1
;
Pan Pan SONG
1
;
Huan GONG
1
;
Xiao Li ZHANG
1
;
Tian Ming JIA
1
Author Information
1. Department of Pediatrics, the Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450002, China.
- Publication Type:Journal Article
- MeSH:
Ataxia/genetics*;
Child;
Electroencephalography;
Epilepsy/genetics*;
Female;
Humans;
Infant;
Infant, Newborn;
Male;
Mutation;
NAV1.2 Voltage-Gated Sodium Channel/genetics*;
Retrospective Studies;
Spasms, Infantile/genetics*
- From:
Chinese Journal of Pediatrics
2022;60(1):51-55
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the clinical manifestations and genetic characteristics of patients with epilepsy and episodic ataxia caused by SCN2A gene variation. Methods: The clinical data of seizure manifestation, imaging examination and genetic results of 5 patients with epilepsy and (or) episodic ataxia because of SCN2A gene variation admitted to the Department of Pediatrics, the Third Affiliated Hospital of Zhengzhou University from July 2017 to January 2021 were analyzed retrospectively. Results: Among 5 patients, 4 were female and 1 was male. The onset age of epilepsy ranged from 4 days to 8 months. There were 2 cases of benign neonatal or infantile epilepsy and 3 cases of epileptic encephalopathy, in whom 1 case had development retardation,1 case transformed from West syndrome to infantile spasm and another one transformed from infantile spasm to Lennox-Gastaut syndrome. One case of benign neonatal-infantile epilepsy was characterized by neonatal onset seizures and episodic ataxia developed at the age of 78 months. Electroencephalograms at first visit of 5 cases showed that 2 cases were normal, 1 case had focal epileptic discharge, and 2 cases had multi-focal abnormal discharge with peak arrhythmia. The brain magnetic resonance imaging (MRI) of 3 cases were nomal, 1 case was abnormal (brain atrophy with decreased white matter) and the results of 1 case was unknown. The follow-up time ranged from 17 months to 89 months. Four cases of epilepsy were controlled and 1 case died at 2 years of age. Two cases had normal intelligence and motor development, 2 had moderate to severe intelligence retardation and motor critical state, and 1 had moderate to severe intelligence and motor development retardation. SCN2A gene variations were identified in all cases. There were 4 missense variations and 1 frameshift variation. Three variations had not been reported so far, including c.4906A>G,c.3643G>T,c.638delT. Conclusions: Variations in SCN2A gene can cause benign neonatal or infantile epilepsy and epileptic encephalopathy. Some children develop episodic ataxia with growing age. The variation of SCN2A gene is mainly missense variation.
